This inventor holds 5 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 4 EPO patents. Top assignees: Development Center for Biotechnology, Dcb-USA LLC. Active years: 2012-2020.
Location History:
- Taipei County, TW (2012)
- New Taipei, TW (2015)
- Xizhi, TW (2012 - 2020)
Company Filing History:
5 out of 96 
2 out of 16 Years Active: 2012-2020
Title: Innovations and Contributions of Inventor Yu-Shen Hsu
Introduction
Yu-Shen Hsu is a notable inventor based in Xizhi, Taiwan, recognized for his significant contributions to the field of biotechnology. With a total of five patents to his name, Hsu has made remarkable advancements in vaccine development and antibody technology.
Latest Patents
One of Hsu's latest patents involves the use of a detoxified recombinant heat-labile enterotoxin mutant, LTS61K, as a carrier protein for polysaccharide conjugation. This innovative approach aims to create vaccines that induce higher polysaccharide-specific IgG titers and greater bactericidal activity compared to traditional methods. Another significant invention is the bispecific T-cell activator antibody, which features unique linker-hinge interface domains that enhance the biological activities of linked molecules. This invention is crucial for activating T-lymphocytes without significant proliferation, showcasing Hsu's expertise in immunology.
Career Highlights
Hsu has worked with prominent organizations such as the Development Center for Biotechnology and DCB-USA LLC. His work in these institutions has allowed him to further his research and development efforts in the biotechnology sector.
Collaborations
Hsu has collaborated with esteemed colleagues, including Ta-Tung Yuan and Young-Sun Lin, contributing to the advancement of innovative solutions in his field.
Conclusion
Yu-Shen Hsu's contributions to biotechnology through his patents and collaborations highlight his role as a leading inventor in vaccine and antibody technology. His work continues to impact the field significantly.